Andreas Evers

2.3k total citations
55 papers, 1.6k citations indexed

About

Andreas Evers is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience. According to data from OpenAlex, Andreas Evers has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 15 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Andreas Evers's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Receptor Mechanisms and Signaling (14 papers) and Neuropeptides and Animal Physiology (12 papers). Andreas Evers is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Receptor Mechanisms and Signaling (14 papers) and Neuropeptides and Animal Physiology (12 papers). Andreas Evers collaborates with scholars based in Germany, France and United States. Andreas Evers's co-authors include Thomas Klabunde, G. Klebe, Michael Wagner, Gerhard Heßler, M. Lorenz, Hans Matter, Holger Gohlke, Martin Bossart, Torsten Haack and Ralf Elvert and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Molecular Biology and Diabetes.

In The Last Decade

Andreas Evers

55 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Evers Germany 21 1.1k 528 281 280 275 55 1.6k
Ivanov As Russia 22 944 0.8× 259 0.5× 101 0.4× 84 0.3× 120 0.4× 183 1.8k
Sylva L. U. Schwager South Africa 24 1.6k 1.4× 465 0.9× 180 0.6× 127 0.5× 70 0.3× 45 2.3k
Minos–Timotheos Matsoukas Greece 19 775 0.7× 231 0.4× 95 0.3× 134 0.5× 112 0.4× 64 1.3k
Mark Namchuk United States 17 1.0k 0.9× 237 0.4× 71 0.3× 135 0.5× 51 0.2× 29 1.7k
Sonia Lobo Planey United States 15 807 0.7× 281 0.5× 129 0.5× 73 0.3× 39 0.1× 26 1.7k
Tina Garyantes United States 10 734 0.6× 390 0.7× 54 0.2× 78 0.3× 65 0.2× 16 1.3k
Allison K. Doak United States 14 1.1k 1.0× 813 1.5× 31 0.1× 127 0.5× 93 0.3× 14 1.8k
John W. Clader United States 28 953 0.8× 230 0.4× 85 0.3× 227 0.8× 127 0.5× 72 3.1k
Marcel Bermúdez Germany 21 915 0.8× 334 0.6× 34 0.1× 379 1.4× 112 0.4× 49 1.3k
Mario Cardozo United States 18 773 0.7× 233 0.4× 67 0.2× 76 0.3× 58 0.2× 31 1.4k

Countries citing papers authored by Andreas Evers

Since Specialization
Citations

This map shows the geographic impact of Andreas Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Evers more than expected).

Fields of papers citing papers by Andreas Evers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Evers. The network helps show where Andreas Evers may publish in the future.

Co-authorship network of co-authors of Andreas Evers

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Evers. A scholar is included among the top collaborators of Andreas Evers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Evers. Andreas Evers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buchanan, Andrew, Eric M. Bennett, Andreas Evers, et al.. (2025). How to think about designing smart antibodies in the age of genAI: integrating biology, technology, and experience. mAbs. 17(1). 2490790–2490790. 3 indexed citations
2.
Becker, Stefan, Jürgen Rödel, Jürgen Scheller, et al.. (2025). Taming interleukin‐12: Engineering of bispecific antibody‐based IL‐12 mimetics with biased agonism capacities. Protein Science. 34(3). e70072–e70072. 4 indexed citations
3.
Pekar, Lukas, Thomas L. Clarke, Lukas Friedrich, et al.. (2023). AI/ML combined with next-generation sequencing of VHH immune repertoires enables the rapid identification of de novo humanized and sequence-optimized single domain antibodies: a prospective case study. Frontiers in Molecular Biosciences. 10. 1249247–1249247. 15 indexed citations
4.
Evers, Andreas, Shipra Malhotra, Maria Borisovska, et al.. (2023). SUMO: In Silico Sequence Assessment Using Multiple Optimization Parameters. Methods in molecular biology. 2681. 383–398. 8 indexed citations
5.
Cao, Jianjun, Matthew J. Belousoff, Elliot Gerrard, et al.. (2023). Structural insight into selectivity of amylin and calcitonin receptor agonists. Nature Chemical Biology. 20(2). 162–169. 10 indexed citations
6.
Evers, Andreas, Lukas Pekar, Achim Doerner, et al.. (2023). Cattle-derived knob paratopes grafted onto peripheral loops of the IgG1 Fc region enable the generation of a novel symmetric bispecific antibody format. Frontiers in Immunology. 14. 1238313–1238313. 4 indexed citations
7.
Pekar, Lukas, Simon Krah, Katja Klausz, et al.. (2023). NKp46‐specific single domain antibodies enable facile engineering of various potent NK cell engager formats. Protein Science. 32(3). e4593–e4593. 19 indexed citations
8.
Kannt, Aimo, Andreas Nygaard Madsen, Ralf Elvert, et al.. (2020). Incretin combination therapy for the treatment of non‐alcoholic steatohepatitis. Diabetes Obesity and Metabolism. 22(8). 1328–1338. 33 indexed citations
9.
Eriksson, Olof, Irina Velikyan, Torsten Haack, et al.. (2019). Assessment of glucagon receptor occupancy by Positron Emission Tomography in non-human primates. Scientific Reports. 9(1). 14960–14960. 7 indexed citations
10.
Velikyan, Irina, Torsten Haack, Martin Bossart, et al.. (2019). First-in-class positron emission tomography tracer for the glucagon receptor. EJNMMI Research. 9(1). 17–17. 18 indexed citations
11.
Elvert, Ralf, Andreas W. Herling, Martin Bossart, et al.. (2018). Running on mixed fuel‐dual agonistic approach of GLP‐1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non‐human primates. Diabetes Obesity and Metabolism. 20(8). 1836–1851. 30 indexed citations
12.
Evers, Andreas, Stefania Pfeiffer‐Marek, Martin Bossart, et al.. (2018). Peptide Optimization at the Drug Discovery-Development Interface: Tailoring of Physicochemical Properties Toward Specific Formulation Requirements. Journal of Pharmaceutical Sciences. 108(4). 1404–1414. 20 indexed citations
13.
Kozian, Detlef, et al.. (2012). Selective non-lipid modulator of LPA5 activity in human platelets. Bioorganic & Medicinal Chemistry Letters. 22(16). 5239–5243. 32 indexed citations
14.
Evers, Andreas, et al.. (2012). Ligand based lead generation - considering chemical accessibility in rescaffolding approaches via BROOD. Journal of Cheminformatics. 4(S1). 11 indexed citations
15.
16.
Hoffmann, Frank, Christoph Sotriffer, Andreas Evers, Guangming Xiong, & Edmund Maser. (2006). Understanding oligomerization in 3α-hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni: An in silico approach and evidence for an active protein. Journal of Biotechnology. 129(1). 131–139. 15 indexed citations
17.
Klabunde, Thomas & Andreas Evers. (2005). GPCR Antitarget Modeling: Pharmacophore Models for Biogenic Amine Binding GPCRs to Avoid GPCR‐Mediated Side Effects. ChemBioChem. 6(5). 876–889. 58 indexed citations
18.
Evers, Andreas, Holger Gohlke, & G. Klebe. (2003). Ligand-supported Homology Modelling of Protein Binding-sites using Knowledge-based Potentials. Journal of Molecular Biology. 334(2). 327–345. 86 indexed citations
19.
Evers, Andreas & G. Klebe. (2003). Ligand‐Supported Homology Modeling of G‐Protein‐Coupled Receptor Sites: Models Sufficient for Successful Virtual Screening. Angewandte Chemie International Edition. 43(2). 248–251. 71 indexed citations
20.
Grimm, Clemens, Andreas Evers, Matthias Brock, et al.. (2003). Crystal Structure of 2-Methylisocitrate Lyase (PrpB) from Escherichia coli and Modelling of its Ligand Bound Active Centre. Journal of Molecular Biology. 328(3). 609–621. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivanov As Breakdown of academic impact, for papers by Sylva L. U. Schwager Breakdown of academic impact, for papers by Minos–Timotheos Matsoukas Breakdown of academic impact, for papers by Mark Namchuk Breakdown of academic impact, for papers by Sonia Lobo Planey Breakdown of academic impact, for papers by Tina Garyantes Breakdown of academic impact, for papers by Allison K. Doak Breakdown of academic impact, for papers by John W. Clader Breakdown of academic impact, for papers by Marcel Bermúdez Breakdown of academic impact, for papers by Mario Cardozo
Rankless by CCL
2026